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Abstract
Background: Surgical repair of ischemic mitral regurgitation 
(IMR) associated with chordal rupture in patients with ischemic 
cardiomyopathy is challenging as it aims to correct several structural 
pathologies at once. There are ongoing studies evaluating multiple 
approaches, however long term results are still scarce.
Methods and Results: 19 patients with IMR underwent mitral valve 
repair with interpapillary polytetrafluoroethylene (PTFE) bridge 
and neochordae formation at the Zala County Teaching Hospital. 
Concomitant coronary artery bypass grafting was performed in all 
patients. Post-procedural Transesophageal Echocardiogram (TEE) 
showed no mitral regurgitation (MR) in eighteen (94.7%) patients, 
with a leaflet coaptation mean height of 8 ± 3 mm. No operative 
mortality was observed. At the follow up (mean 17.7 ± 4.6 months; 
range 9 to 24 months), 17 (89%) patients showed no leakage and 
2 had regurgitation grade ≤1, with documented NYHA functional 
class I or II in all patients.
Conclusion: This retrospective study presents the first results of a 
novel surgical approach to treating ischemic mitral regurgitation. The 
interpapillary PTFE bridge formation is a safe and feasible surgical 
procedure that is reproducible, time sparing and effectively eliminates 
mitral valve regurgitation with promising long-term results.
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Introduction
Ischemic heart disease is the most frequent cause of mitral 
regurgitation (MR) today, particularly in developed countries 
where rheumatic mitral valve disease has been nearly eradicated [1]. 
Ischemic mitral regurgitation (IMR) is caused by a complex interplay 
of abnormal structural and functional processes [2]. The surgical 
treatment of choice for most cases of IMR is mitral valve repair, 
because it preserves the mitral apparatus and competence, does not 
require the lifelong anticoagulation, [3] and is associated with an 
improved quality of life with less morbidity as well as better long-
term survival as opposed to replacement [4]. 
Since the mitral apparatus is a 3-dimensional functional 
valvular unit that comprises the left atrial wall, the mitral annulus, 
the two mitral leaflets, the subvalvular chordae tendineae, the 
papillary muscles, and the adjacent left ventricular wall, [5] the 
pathophysiologic processes that eventually lead to IMR are manifold, 
including left ventricle wall motion abnormalities; left ventricular 
remodelling leading to lateral and apical displacement of papillary 
muscles; annular dilation; alterations in the geometry of the inflow 
tract; restricted leaflet motion in systole; leaflet prolapse; and/or 
chordal rupture. We believe that such complex pathology suggests 
that proper approaches to its repair should target both valvular and 
subvalvular apparatus equally. 
Although several procedures have been described to correct 
chronic IMR [6-8], an optimal procedure that is time sparing and 
corrects most aspects of the pathology have not yet been defined, 
and the long-term follow-up data are still scarce. Our study sought 
to present the first results of a novel method that approximates the 
displaced papillary muscles and implants sufficient neochordae as an 
adjunct procedure to annuloplasty and myocardial revascularization.
Methods
The study was designed as a single-center prospective feasibility 
study of patients who underwent mitral valve repair at the Zala 
County Hospital. Patients must have had ischemic mitral valve 
regurgitation (IMR) to be eligible for inclusion. All study protocols 
were approved by the Zala County Teaching Hospital & Pécs 
University of Science. Written patient’s consent was obtained in all 
cases. We began performing this technique in the beginning of 2007.
19 patients underwent mitral valve repair for ischemic mitral 
regurgitation (IMR) using a novel procedure that involved 
interpapillary polytetrafluoroethylene (PTFE) bridge and neochordae 
formation. For all 19 cases our surgical technique was as follows: after 
pericardiotomy reef and surgical knots were performed maximum 2 
centimeters from each other with two double armed, 4-0 PTFE threads 
(Figure 1A-1C). Autologous pericardial pledgets were attached to 
lock these knots (Figure 1D). After completing the coronary artery 
bypass procedure either with or without cardiopulmonary bypass, the 
mitral valve was exposed through left interatrial groove cardiotomy. 
Marks indicating the length of the reference chordae were made on 
the PTFE free threads using a skin marker pen. One of the knotted 
threads was inserted through the posteromedial papillary muscle 
from the middle to the right, and the other thread through the 
anterolateral papillary muscle from the middle to the left forming 
an interpapillary muscle bridge, which approximates the papillary 
muscles to a distance of ≤2 cm (Figure 2A). Pledgets (which prevent 
their potential penetration into the scarring muscle) are not needed 
on the lateral sides of the papillary muscles, as knots are not placed 
on this side. The free ends of this bridge on the lateral side of the 
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papillary muscles were used as neochordae and were passed though 
the prolapsed or ruptured coaptation zone and tied on the level of the 
pen marks. When necessary, additional neochordae were anchored to 
the interpapillary bridge, by forming a lark’s head knot (Figure 2B). 
Restrictive mitral annuloplasty was performed subsequently.
Outcomes were evaluated on two separate occasions: 
preoperatively, and at a long-term follow-up visit. Perioperative 
assessment of immediate outcomes was performed by trans-
esophageal echocardiography (TEE). Long-term postoperative 
evaluation was done on an outpatient basis at a mean of 17.7 
months after surgery with cardiologic assessment and trans-thoracic 
echocardiography (TTE).
Results
Nineteen patients (15 males), aged 63 ± 7.7 years with chronic IMR 
were operated on using our novel procedure. Thirteen patients (68%) 
had New York Heart Association (NYHA) functional class III or IV 
congestive heart failure preoperatively. Mean data of preoperative 
echocardiographic findings were as follows: left ventricular ejection 
fraction: 37 ± 7%, mitral regurgitation grade: 3.3 ± 0.6, left ventricular 
end-diastolic diameter: 63 ± 8 mm, regurgitant volume: 42 ± 8 mL, 
and distance between the two papillary muscle heads in systole: 31 ± 3 
mm (Table 1). Posterior or anterior leaflet prolapses were detected in 
three cases and chordal rupture of P2, P3, A2 and A3 segments were 
detected in case number 12, 3, 1 and 2, respectively. The implanted 
ring’s median size was 32 mm. Concomitant coronary artery bypass 
grafting was performed in all patients, and total aortic cross clamp 
mean time was 74 ± 7 min. TEE at the end of surgery showed no 
MR in eighteen (94.7%) patients, with a leaflet coaptation mean 
height of 8 ± 3 mm (Table 2). No operative mortality was observed. 
At the follow up (mean 17.7 ± 4.6 months; range 9 to 24 months) 
17 (89%) patients showed no leakage and 2 had regurgitation grade 
≤1. Mean left ventricular ejection fraction was 48 ± 9% and mean left 
ventricular end-diastolic diameter was 56.3 ± 5.2. No valve-related 
complications were observed and no re-interventions were necessary. 
One patient died at 13 months postoperatively due to extracardiac 
morbidity. Overall survival was 94.7%. NYHA functional class I or II 
was documented in 83.3% of these patients (Table 3).
Discussion
Although surgical treatment for primary mitral regurgitation 
is relatively straightforward, the management for chronic IMR is 
considerably more controversial [9]. Carpentier’s techniques which 
generally involve resection of abnormal or pathologic tissue with 
precise reconstruction toward ‘normal valve anatomy’ remain the 
most commonly performed world-wide, and are associated with 
excellent long-term outcomes [10,11]. However, a new concept of 
‘respect rather than resect’ tissue has become popular in recent years. 
It is based on the use of polytetrafluoroethylene (PTFE) neochordae 
to reconstruct support of the free edge of prolapsing segments, and 
to ‘displace’ abnormal excess tissue into the ventricle ensuring a 
good surface of coaptation [12]. Although our approach falls into 
the category of the latter, tissue preserving methodology, to our best 
knowledge, the technique of approximating the papillary muscles 
with an interpapillary bridge, have never been published before. 
Our team believes that the complexity of chronic IMR pathology 
indicates that surgical repair of this disease must target the 
dysfunctions of the valvular and subvalvular apparatus equally. This 
Figure 1: A,B: tuft a reef knot. C: creating a surgical knot maximum 
2 centimeters far away from the reef knot. D: insertion of pericardial 
pledgets.
 
Figure 2: A: Creating interpapillary muscle bridge and neochordae. 
B: Forming an additional neochordae.
EF: Ejection Fraction; MR, Mitral Regurgitation; LVED: Left Ventricular End-
diastolic Diameter
*Diameter was measured during systole
Age 63 ± 7.7
Male 15
EF 37 ± 7%,
MR grade 3.3 ± 0.6
LVED 63 ± 8 mm
Regurgitant Volume 42 ± 8 mL
Interpapillary distance* 31 ± 3 mm
Table 1: Main preoperative patient’s and echocardiographic variables.
Aortic cross clamp time 74 ± 7 minutes
CABG, graft No. 2.3 ± 0,9
Coaptation height on TEE 8 ± 3 mm
Operative mortality 0%
Table 2: Main intraoperative variables.
Follow-up time 17.7 ± 4.6 months
EF at follow-up 48 ± 9%
LVED at follow-up 56.3 ± 5.2
Overall survival 94.70%
EF: Ejection Fraction; LVED: Left Ventricular End-diastolic Diameter
Table 3: Main follow-up variables.
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concept is re-enforced by the fact that there is a high recurrence rate 
of MR after performing mitral annuloplasty alone in chronic IMR 
[13]. A variety of techniques on the subvalvular apparatus have been 
described to correct chronic IMR offering good results [6-8], but 
almost all of them are time consuming and technically demanding. 
Leaflet prolapse and/or chordae rupture as a combined pathology to 
chronic IMR can cause additional surgical challenges [14].
Taking the above mentioned concepts into consideration 
we developed and successfully applied a novel surgical approach 
to repairing IMR, by approximating the papillary muscles using 
interpapillary PTFE thread in a “bridge like” fashion, which also 
functions as artificial chordae on the sides. By anchoring additional 
threads to the interpapillary muscle bridge we can easily raise the 
number of the neochordae. We hypothesize that the joint power of 
papillary muscles can be increased by approximating them to each 
other, which redistributes the left intraventricular pressure, which 
in turn leads to a reduction of shear forces on the two muscles, 
the artificial chordae, and the reconstructed scallop‏. This method 
is effective in eliminating chronic IMR and theoretically it could 
be useful in reconstruction of other forms of mitral regurgitation 
demanding neochordal implantation or in minimally invasive 
approaches. According to our experience this technique is simple, 
reproducible and time sparing.
Limitations
While this is a single-center study with a small sample size, it 
was designed as a feasibility study to propose a novel procedure, 
which will need to be further validated by additional studies. Control 
groups, long term follow up and force measurements on the mitral 
valve apparatus are mandatory for further evaluation of this method.
Conclusions
The interpapillary polytetrafluoroethylene bridge formation 
is a safe and feasible surgical procedure that is reproducible, time 
sparing and effectively eliminates mitral valve regurgitation in the 
postoperative phase with promising long-term results. 
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